搜索筛选:
搜索耗时1.2615秒,为你在为你在102,285,761篇论文里面共找到 1,000 篇相符的论文内容
发布年度:
Clinical Pharmacology Research in ChinaPast and Present--A story of an innovative target antitumor d
[会议论文] 作者：Pei Hu,
来源：第五届定量药理学与新药评价国际会议 年份：2015
Outline· Past-There was no guidance in those early years -Mainly conducted BE trials of generic drugs -Generic PK trials of imported drugs requested by SFDA ·...
[会议论文] 作者：HU Pei,
来源：2015年第一届药代动力学朝阳论坛 年份：2015
In the recent years the more and more innovative drugs have been developed in China.It changes the mode of early phase clinical trials in China.To accommoda...
[期刊论文] 作者：Hu Yuanmu Liu Pei,
来源：Review of Global Academics 年份：2015
...
Alternative Methods for CYP2D6 Phenotyping: Comparison of Dextromethorphan Metabolic Ratios from AUC
[会议论文] 作者：Rui Chen,Pei Hu,
来源：第十四届全国生化与分子药理学学术会议 年份：2015
...
[会议论文] 作者：Dongyang Liu,Pei Hu,
来源：第五届定量药理学与新药评价国际会议 年份：2015
...
Alternative Methods for CYP2D6 Phenotyping: Comparison of Dextromethorphan Metabolic Ratios from AUC
[会议论文] 作者：Rui Chen,Pei Hu,
来源：第十四届全国生化与分子药理学学术会议 年份：2015
Purpose:Cytochrome P450 2D6 (CYP2D6) is one of the most widely investigated polymor phic enzymes owing to its wide inter-individual and inter-ethnic variations.It is convenient to test genotypes clini...
Evaluation of the phenotyping methods of CYP2D6 using aphysiologically-based pharmacokinetic model o
[会议论文] 作者：Rui Chen,Pei Hu,
来源：第五届定量药理学与新药评价国际会议 年份：2015
Background and Aim: Hepatic enzyme CYP2D6 plays an important role in metabolizing many drugs and its genetic polymorphism results in significant individual therapeutic difference.Estimating the phenot...
[期刊论文] 作者：Li MA,Zu-ncng LU,Pei HU,Chang-,
来源：华中科技大学学报：医学英德文版 年份：2015
The neuroprotective effects of escitalopram oxalate in rats with chronic hypoperfusion and the possible mechanism were explored. Chronic hypoperfusion(2-VO) mod...
[期刊论文] 作者：WANG Jie PEI Xi CAO Rui-Fen HU,
来源：核技术：英文版 年份：2015
Optimization of the inverse planning becomes critical because it follows the invention of intensity modulated radiotherapy(IMRT) to shorten the previous 'tr...
Development of a multiplex reverse transcription-PCR assay for simultaneous detection of garlic viru
[期刊论文] 作者：HU Xin-xi,LEI Yan,WANG Pei,TAN,
来源：农业科学学报：英文版 年份：2015
A preliminary screening for garlic viruses in garlic plants in Hunan,China,using existing monoplex(simplex) reverse transcription-polymerase chain reaction(RT-P...
[期刊论文] 作者：Li MA,Zu-neng LU,Pei HU,Chang-,
来源：华中科技大学学报（医学英德文版） 年份：2015
...
[期刊论文] 作者：ZHAO Pei,ZHANG Xupu,YANG Dacheng,HU Xiaoyan,,
来源：中国通信 年份：2015
In order to expand the cell coverage of wireless cellular systems, the number of passive components in wireless systems has been substantially increased. There...
[会议论文] 作者：Rong Hu,Wu Xing,Wang Feimiao,Pei Liguo,
来源：中华医学会第四次全国实验室学组学术会议 年份：2015
...
Predictions about probabilities of adverse events and appropriate dose of roflumilast for Chinese CO
[会议论文] 作者：Xinge Cui,Xin Zheng,Pei Hu,Ji Jiang,
来源：第五届定量药理学与新药评价国际会议 年份：2015
...
Population pharmacokinetic pharmacodynamics model for PEGylated human growth hormone in healthy subj
[会议论文] 作者：Xin Zheng,Xia Chen,Pei Hu,Ji Jiang,
来源：第五届定量药理学与新药评价国际会议 年份：2015
...
Application of population pharmacokinetic modeling in clinical development of a novel PPI CPRCX: com
[会议论文] 作者：Xuemei Liu,Hongyun Wang,Pei Hu,Ji Jiang,
来源：第五届定量药理学与新药评价国际会议 年份：2015
...
Population pharmacokinetics of CPRC1 in patients with duodenal ulcer following intravenous administr
[会议论文] 作者：LIU Xue-mei,WANG Hong-yun,HU Pei,JIANG Ji,
来源：2015年第一届药代动力学朝阳论坛 年份：2015
CPRC1 is a novel investigated proton pump inhibitor, which shows dramaticsuccess in the management of acid-related disorders.Now this drug is being developed in Phase Ⅱ study in China.In this paper fo...
Application of population pharmacokinetic modeling in clinical development of a novel PPI CPRCX: com
[会议论文] 作者：Xuemei Liu,Hongyun Wang,Pei Hu,Ji Jiang,
来源：第五届定量药理学与新药评价国际会议 年份：2015
CPRCX is a novel investigated proton pump inhibitor, which shows dramatic success in the management of acid-related disorders.Now this drug is being developed in Phase Ⅱ study in China.In this paper f...
Population pharmacokinetic pharmacodynamics model for PEGylated human growth hormone in healthy subj
[会议论文] 作者：Xin Zheng,Xia Chen,Pei Hu,Ji Jiang,
来源：第五届定量药理学与新药评价国际会议 年份：2015
Background: Growth hormone deficiency (GHD) in paediatric and adult patients so currently necessitates long-term treatment and persistence with a daily s.c injection regimen.Taking the low compliance...
Predictions about probabilities of adverse events and appropriate dose of roflumilast for Chinese CO
[会议论文] 作者：Xinge Cui,Xin Zheng,Pei Hu,Ji Jiang,
来源：第五届定量药理学与新药评价国际会议 年份：2015
Backgrounds: Roflumilast is an oral inhibitor of phosphodiesterase 4(PDE4), which is mainly metabolized by CYP3A4 and CYP1A2.The main metabolite of it is roflumilast N-oxide, which contributes to the...
相关搜索：
